|
GGNBP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.875600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.460390E-03 |
| Normal-vs-Stage2 |
2.832400E-01 |
| Normal-vs-Stage3 |
3.491000E-01 |
| Normal-vs-Stage4 |
4.283600E-01 |
| Stage1-vs-Stage2 |
4.095000E-01 |
| Stage1-vs-Stage3 |
1.197990E-04 |
| Stage1-vs-Stage4 |
9.952900E-04 |
| Stage2-vs-Stage3 |
1.030840E-01 |
| Stage2-vs-Stage4 |
1.258190E-01 |
| Stage3-vs-Stage4 |
9.534000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.623850E-01 |
| Normal-vs-AfricanAmerican |
1.863610E-01 |
| Normal-vs-Asian |
5.350000E-02 |
| Caucasian-vs-AfricanAmerican |
5.339200E-01 |
| Caucasian-vs-Asian |
3.368800E-01 |
| AfricanAmerican-vs-Asian |
5.139200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.066200E-01 |
| Normal-vs-Female |
2.538700E-03 |
| Male-vs-Female |
2.960100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.835200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.397900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.502950E-01 |
| Normal-vs-Age(81-100Yrs) |
5.349400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.141900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.090430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.782400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.556000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.940000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.908200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.73090000005405E-07 |
| Normal-vs-Grade 2 |
7.005500E-04 |
| Normal-vs-Grade 3 |
7.685600E-01 |
| Normal-vs-Grade 4 |
3.939500E-02 |
| Grade 1-vs-Grade 2 |
1.263520E-02 |
| Grade 1-vs-Grade 3 |
2.043100E-04 |
| Grade 1-vs-Grade 4 |
6.6070000004359E-07 |
| Grade 2-vs-Grade 3 |
1.057930E-03 |
| Grade 2-vs-Grade 4 |
2.38409999997469E-06 |
| Grade 3-vs-Grade 4 |
2.454300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.61969995591005E-09 |
| Normal-vs-ccB subtype |
5.562800E-03 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.144200E-01 |
| Normal-vs-N1 |
3.245600E-01 |
| N0-vs-N1 |
2.435200E-01 |
|
|
